Elizabeth F. Juniper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elizabeth F. Juniper has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Ann-Christin Mörk
AstraZeneca R&D, Lund, S-221 87, Sweden
3 shared publicationsKlas Svensson
AstraZeneca R&D, Lund, S-221 87, Sweden
3 shared publicationsP M O'Byrne
2 shared publications- Paul M. O'BYrne
McMaster University
2 shared publications A.H. Emmett
1 shared publication- Ann-Christin Mörk
Formerly of AstraZeneca, Lund, Sweden
1 shared publication
Latest Publications
- Open Access
- 7 June 2010
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 36 (6) , 1410-1416
Asthma Control Questionnaire in children: validation, measurement properties, interpretation
The Asthma Control Questionnaire (ACQ) has been validated in adults to measure the primary goal of management (minimisation of symptoms, activity limitations, short-acting β2-agonist use and airway narrowing). The present study evaluated the validity, measurement properties and interpretability of the ACQ in children aged 6–16 yrs.35 children attended clinic on three occasions (0, 1 and 4 weeks) and completed the ACQ, Mini Paediatric Asthma Quality of Life Questionnaire and the Royal College of Physicians’ “Three Questions”. Parents completed the Paediatric Asthma Caregiver’s Quality of Life Questionnaire. Between visits, children completed the Asthma Control Diary and measured peak expiratory flow. At weeks 1 and 4, clinicians and parents completed Global Rating of Change Questionnaires.All patients completed the study. 19 children were stable between two assessments and provided evidence of good test–retest reliability (intraclass correlation coefficient 0.79). The ACQ was responsive to change in asthma control (p = 0.026) and the mean±sdMinimal Important Difference was 0.52±0.45. Both cross-sectional and longitudinal correlations between the ACQ and the other outcomes were close to predicted and provided evidence that the ACQ measures asthma control in children.The ACQ has strong measurement properties and is valid for use in children aged 6–16 yrs. In children aged 6–10 yrs, it must be administered by a trained interviewer.
- 7 June 2010
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 36 (6) , 1410-1416
Open AccessAsthma Control Questionnaire in children: validation, measurement properties, interpretation
The Asthma Control Questionnaire (ACQ) has been validated in adults to measure the primary goal of management (minimisation of symptoms, activity limitations, short-acting β2-agonist use and airway narrowing). The present study evaluated the validity, measurement properties and interpretability of the ACQ in children aged 6–16 yrs.35 children attended clinic on three occasions (0, 1 and 4 weeks) and completed the ACQ, Mini Paediatric Asthma Quality of Life Questionnaire and the Royal College of Physicians’ “Three Questions”. Parents completed the Paediatric Asthma Caregiver’s Quality of Life Questionnaire. Between visits, children completed the Asthma Control Diary and measured peak expiratory flow. At weeks 1 and 4, clinicians and parents completed Global Rating of Change Questionnaires.All patients completed the study. 19 children were stable between two assessments and provided evidence of good test–retest reliability (intraclass correlation coefficient 0.79). The ACQ was responsive to change in asthma control (p = 0.026) and the mean±sdMinimal Important Difference was 0.52±0.45. Both cross-sectional and longitudinal correlations between the ACQ and the other outcomes were close to predicted and provided evidence that the ACQ measures asthma control in children.The ACQ has strong measurement properties and is valid for use in children aged 6–16 yrs. In children aged 6–10 yrs, it must be administered by a trained interviewer.
- 30 October 2009
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 34 (5) , 1015-1017
Validated questionnaires should not be modified
- 30 October 2009
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 34 (5) , 1015-1017
Validated questionnaires should not be modified
- 1 June 2009
- Published by Elsevier in Respiratory Medicine
- Vol. 103 (6) , 932-934
Patients may respond differently to paper and electronic versions of the same questionnaires
- 1 June 2009
- Published by Elsevier in Respiratory Medicine
- Vol. 103 (6) , 932-934
Patients may respond differently to paper and electronic versions of the same questionnaires
- 3 February 2009
- Published by Springer Nature in Quality of Life Research
- Vol. 18 (5) , 531-533
Modification, translation and adaptation of questionnaires should copyright laws be observed?
This commentary is intended to start a discussion about whether people should be allowed to modify, translate, adapt or sell copyrighted questionnaires without the permission of the developer (copyright-holder).
- 3 February 2009
- Published by Springer Nature in Quality of Life Research
- Vol. 18 (5) , 531-533
Modification, translation and adaptation of questionnaires should copyright laws be observed?
This commentary is intended to start a discussion about whether people should be allowed to modify, translate, adapt or sell copyrighted questionnaires without the permission of the developer (copyright-holder).
- 28 August 2007
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 7 (5) , 390-394
Assessing asthma control
Guidelines for the treatment of asthma have identified that the primary goal of management is achieving good asthma control, thus reducing the risk of exacerbations. Research has shown, however, that the accuracy with which clinicians can estimate the adequacy of control may not be very good. Nor are clinicians accurate in estimating change in asthma control between clinic visits. Simple questionnaires to measure asthma control are now available, and can be used to evaluate the adequacy of control and to monitor whether levels of control change between assessments. This article discusses selection of a questionnaire, interpretation of data obtained, and methods of administration.
- 28 August 2007
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 7 (5) , 390-394
Assessing asthma control
Guidelines for the treatment of asthma have identified that the primary goal of management is achieving good asthma control, thus reducing the risk of exacerbations. Research has shown, however, that the accuracy with which clinicians can estimate the adequacy of control may not be very good. Nor are clinicians accurate in estimating change in asthma control between clinic visits. Simple questionnaires to measure asthma control are now available, and can be used to evaluate the adequacy of control and to monitor whether levels of control change between assessments. This article discusses selection of a questionnaire, interpretation of data obtained, and methods of administration.
- Top Cited Papers
- 1 April 2006
- Published by Elsevier in Respiratory Medicine
- Vol. 100 (4) , 616-621
Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire
- 1 April 2006
- Published by Elsevier in Respiratory Medicine
- Vol. 100 (4) , 616-621
Top Cited PapersIdentifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire
- Open Access
- 16 September 2005
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 3 (1) , 1-58
Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older
Background: The age limit for some adult asthma clinical trials has recently been lowered to 12 years. In this study we have made minor modifications to the standardised version of the adult Asthma Quality of Life Questionnaire (AQLQ(S)) to make it valid for patients 12 years and older (AQLQ12+).Methods: We have used two clinical trial databases, in which the AQLQ12+ was used, to compare the measurement properties of the questionnaire in patients 12–17 years and patients 18 years and older. A total of 2433 patients (12–75 years), with current asthma and with data that could be evaluated both at randomisation and end of treatment, were included.Results: The analysis showed that internal consistency, responsiveness and correlations with other clinical indices were very similar in patients 12–17 years and patients 18 years and older.Conclusion: The measurement properties of the AQLQ12+ are similar in adolescents and adults and therefore the instrument is valid for use in adult studies which include children 12 years and older.
- 16 September 2005
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 3 (1) , 1-58
Open AccessModification of the asthma quality of life questionnaire (standardised) for patients 12 years and older
Background: The age limit for some adult asthma clinical trials has recently been lowered to 12 years. In this study we have made minor modifications to the standardised version of the adult Asthma Quality of Life Questionnaire (AQLQ(S)) to make it valid for patients 12 years and older (AQLQ12+).Methods: We have used two clinical trial databases, in which the AQLQ12+ was used, to compare the measurement properties of the questionnaire in patients 12–17 years and patients 18 years and older. A total of 2433 patients (12–75 years), with current asthma and with data that could be evaluated both at randomisation and end of treatment, were included.Results: The analysis showed that internal consistency, responsiveness and correlations with other clinical indices were very similar in patients 12–17 years and patients 18 years and older.Conclusion: The measurement properties of the AQLQ12+ are similar in adolescents and adults and therefore the instrument is valid for use in adult studies which include children 12 years and older.
- Top Cited Papers
- 1 May 2005
- Published by Elsevier in Respiratory Medicine
- Vol. 99 (5) , 553-558
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
- 1 May 2005
- Published by Elsevier in Respiratory Medicine
- Vol. 99 (5) , 553-558
Top Cited PapersMeasurement properties and interpretation of three shortened versions of the asthma control questionnaire
- Open Access
- 1 March 2005
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 1 (3) , 192-204
Assessing asthma quality of life: its role in clinical practice
Key points Asthma patients want help to improve their ability to function in their daily lives (physical, social, occupational and emotional). Awareness of patients’ problems and a willingness to treat them may improve both asthma control and quality of life. The clinician and the patient should negotiate a treatment plan that addresses both asthma control and the patient's needs, and that the patient is willing to follow. Valid, easy-to-use, self-administered asthma quality-of-life questionnaires can be used in the clinic to identify quickly the patient's specific problems and treatment goals. Educational aims To define HRQL and emphasise its importance in patients with asthma. To describe the HRQL impairments experienced by adults and children with asthma. To discuss the role of HRQL in clinical practice and the concept of shared decision making. To provide information on the selection, methods of administration, analysis, interpretation and cultural adaptation of HRQL questionnaires Summary An important contributor to poor patient compliance with treatment instructions may be a discrepancy between the goals of the clinician and those of the patient. Improved clinician awareness of patients’ asthma-related quality-of-life goals and a readiness to address them may enhance patients’ willingness to take medications and, thus, improve both their asthma control and their quality of life. The aim of this article is to explain how quick, valid, easy-to-use, self-administered and clinic-friendly HRQL can be used to identify patients’ greatest needs, ascertain how troublesome they are and ensure that they are included in the treatment plan. HRQL questionnaires can also be used to monitor patient progress over time.
- 1 March 2005
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 1 (3) , 192-204
Open AccessAssessing asthma quality of life: its role in clinical practice
Key points Asthma patients want help to improve their ability to function in their daily lives (physical, social, occupational and emotional). Awareness of patients’ problems and a willingness to treat them may improve both asthma control and quality of life. The clinician and the patient should negotiate a treatment plan that addresses both asthma control and the patient's needs, and that the patient is willing to follow. Valid, easy-to-use, self-administered asthma quality-of-life questionnaires can be used in the clinic to identify quickly the patient's specific problems and treatment goals. Educational aims To define HRQL and emphasise its importance in patients with asthma. To describe the HRQL impairments experienced by adults and children with asthma. To discuss the role of HRQL in clinical practice and the concept of shared decision making. To provide information on the selection, methods of administration, analysis, interpretation and cultural adaptation of HRQL questionnaires Summary An important contributor to poor patient compliance with treatment instructions may be a discrepancy between the goals of the clinician and those of the patient. Improved clinician awareness of patients’ asthma-related quality-of-life goals and a readiness to address them may enhance patients’ willingness to take medications and, thus, improve both their asthma control and their quality of life. The aim of this article is to explain how quick, valid, easy-to-use, self-administered and clinic-friendly HRQL can be used to identify patients’ greatest needs, ascertain how troublesome they are and ensure that they are included in the treatment plan. HRQL questionnaires can also be used to monitor patient progress over time.